openPR Logo
Press release

HIV Diagnostics and Treatment Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025

08-17-2021 12:47 PM CET | Health & Medicine

Press release from: Orion Market Research

The global HIV diagnosis and treatment market is estimated to grow at a CAGR of 7.6%, during the forecast period. Rising incidence and prevalence rate of HIV infection across the globe coupled with the technological development of diagnostic tests, such as rapid CD4, EID test and regulatory authority such as approval of POC (point of care testing) for detection of HIV), is driving the market growth. According to the Joint United Nations Program on HIV and AIDS (UNAID), more than 36.7 million people across the globe have HIV and around 1.8 million children had HIV infection in 2017. The FDA performed the clinical value of HIV diagnostic assay and blood screening and regulates the study to create product standard and incorporated enhanced diagnostic methods to enables the safety of drugs and biologics. The multidisciplinary research program plays a vital role in the establishment of test kits, vaccines, therapeutics agents for utilization in AIDS. Government support will support the growth of the HIV diagnostics and treatment market.

To Request a Sample of our Report on HIV Diagnostics and Treatment Market: https://www.omrglobal.com/request-sample/hiv-diagnostics-and-treatment-market

The HIV diagnosis and treatment market is growing due to government initiatives, rising awareness about HIV and growing number of blood donation is the reason for the increase in a number of AIDs infection. It is a basic requirement for the treatment of HIV in underdeveloped nation need for technological equipment; however, the scarcity of funds and inaccuracy of the tests and with unskilled professionals are hampering the market growth of HIV diagnostics and treatment market.

(Get 15% Discount on Buying this Report)

A full Report of HIV Diagnostics and Treatment Market is Available at: https://www.omrglobal.com/industry-reports/hiv-diagnostics-and-treatment-market

HIV Diagnostics and Treatment Market Segmentation

By Test Type

· Antibody Tests

· HIV-1 Screening Tests

· HIV-1 Antibody Confirmatory Tests

· HIV-2 & Group O Diagnostics Tests

· Viral Identification Assays

· CD4 Testing

· Viral Load Testing

· Early Infant Diagnostics

By Diagnostics Products

· Kits and Reagents

· Instruments

By Treatment

· Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)

· Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS)

· Integrase Inhibitors

· Others (Protease Inhibitors (PIS))

By End-User

· Diagnostics Laboratory

· Hospitals

· Blood Banks

· Home Care Settings

· Others (Academic and Research Institutes)

Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of The World

Company Profiles

· Abbott Laboratories

· AbbVie Inc.

· Becton, Dickinson and Co.

· Bio-Rad Laboratories, Inc.

· bioMérieux SA

· Boehringer Ingelheim International GmbH

· Bristol-Myers Squibb Co.

· Cipla Inc.

· F. Hoffmann-La Roche Ltd.

· Gilead Sciences, Inc.

· GlaxoSmithKline PLC

· Hologic, Inc.

· Johnson & Johnson Services, Inc.

· Merck & Co., Inc.

· Mylan N.V.

· Pfizer Inc.

· QIAGEN N.V.

· Siemens AG

· Sysmex Corp.

· ViiV Healthcare

Reasons to Buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hiv-diagnostics-and-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Diagnostics and Treatment Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025 here

News-ID: 2357413 • Views:

More Releases from Orion Market Research

Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovations LLC (US), Park Premium Ingredients (US)
Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovation …
The global Eggshell Membrane Market was valued at approximately USD 173.78 million in 2024, and is projected to reach USD 396.55 million by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033. Eggshell Membrane Market Overview The Eggshell Membrane Market is experiencing significant growth, driven by increasing consumer awareness of its health benefits, particularly in joint health and skin care. This natural biopolymer, rich in proteins
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor Group, Dyesol Ltd (Greatcell Solar), Eight19 Ltd, Toshiba Corporation
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor G …
The global Printable Solar Cells Market was valued at approximately USD 1.2 billion in 2024, and is projected to reach USD 4.8 billion by 2033, exhibiting a strong compound annual growth rate (CAGR) of 16.7% from 2025 to 2033. Printable Solar Cells Market Overview The Printable Solar Cells Market is on a rapid upward trajectory, led by rising demand for flexible, lightweight, and cost-effective energy solutions. Printable photovoltaic technologies-including organic, perovskite,
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Pl …
The Sales Enablement Software Market was valued at approximately USD 3.4 billion in 2024 and is projected to reach around USD 13.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2033. Sales Enablement Software Market Overview The Sales Enablement Software Market is experiencing significant growth, driven by the increasing need for businesses to enhance their sales processes and improve team performance. These platforms
Feed management software Market Set to Witness Significant Growth by 2033 | Prairie Systems, Dairy Records Management Systems (DRMS)
Feed management software Market Set to Witness Significant Growth by 2033 | Prai …
The global Feed Management Software Market was estimated to be around USD 0.6 billion in 2024, and is projected to reach approximately USD 1.2 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Feed Management Software Market Overview The Feed Management Software Market is expanding steadily as the agriculture and livestock industries shift toward digital transformation to optimize feed formulation and reduce

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways